Phase I study of oxaliplatin in patients with advanced cancer

Cancer Chemotherapy and Pharmacology

Volumn 25, Issue 4, 1990, Pages 299-303

  Extra, Jean Marc ^a   Espie, Marc ^a   Calvo, Fabien ^a   Ferme, Christophe ^b   Mignot, Laurent ^c   Marty, Michel ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Centre Hospitalier de Bligny   (France)

^c FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; ETHNIC OR RACIAL ASPECTS; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HEMATOLOGIC DISEASES; HUMAN; MALE; MIDDLE AGE; NEOPLASMS; NERVOUS SYSTEM DISEASES; ORGANOPLATINUM COMPOUNDS; PARESTHESIA; VOMITING;

EID: 0025020085     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00684890     Document Type: Article

References (26)

1. Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination chemotherapy in patients with locally advanced head and neck cancer
2. Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiamminoplatinum (II)
3. Antitumor activity of platinum analogs
4. High-dose cisplatin in advanced head and neck cancer
5. Modified dose schedule of high-dose cisplatin. Reduced toxicity and correlation with plasma pharmacokinetics. A Northern California Oncology Group pilot study in non-small-cell lung cancer
6. Neuropathie périphérique au cisplatine. Une observation
7. Peripheral neuropathy associated with cis-dichlorodiammine platinum(II) treatment
8. Peripheral neuropathy as a complication of cis-dichlorodiammine platinum(II) treatment: a case report
9. Antitumor activity of 1,2-diaminocyclohexane-platinum complexes against sarcoma-180 ascites form
10. Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes
11. Antitumor activity of platinum(II) complexes of 1,2-diamino cyclohexane isomers
12. High dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity
13. Antitumor activity of 1-OHP in mice
14. A phase I trial of trans-1-diaminocyclohexane oxalatoplatinum (1-OHP)
15. Treatment of genitourinary tumors with cis-dichlorodiammine platinum(II): experience in 250 patients
16. cis-Dichlorodiammine platinum and Adriamycin therapy for advanced gynecological and genitourinary neoplasms
17. High dose cisplatin in hypertonic saline
18. High dose cisplatin in hypertonic saline in refractory ovarian cancer
19. Cisplatinum toxicity: an analysis based on three SWOG studies
20. Péripheral sensory neuropathy and cisplatin chemotherapy
21. Cisplatin neurotoxicity: failure to demonstrate vitamin B12 inactivation
22. Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms
23. Demyelination of peripheral nerves associated with cis-diamminedichloroplatinum(II) (DDP) therapy
24. Ovarian trials at the Royal Marsden
25. Cancer of the ovary